Pliant Therapeutics, Inc. (PLRX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Bernard Coulie
Employees:
90
260 LITTLEFIELD AVENUE, SOUTH SAN FRANCISCO, CA 94080
650-481-6770

Pliant Therapeutics, Inc. discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins.

Data derived from most recent annual or quarterly report
Market Cap 785.239 Million Shares Outstanding36.169 Million Avg 30-day Volume 713.242 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.28
Price to Revenue29.4249 Debt to Equity0.0668 EBITDA-109.565 Million
Price to Book Value1.9606 Operating Margin-1112.6739 Enterprise Value136.021 Million
Current Ratio7.694 EPS Growth-0.647 Quick Ratio7.475
1 Yr BETA 0.6957 52-week High/Low 24.17 / 3.97 Profit Margin-1109.1906
Operating Cash Flow Growth-33.5512 Altman Z-Score1.7281 Free Cash Flow to Firm -70.759 Million
Earnings Report2022-11-08
View SEC Filings from PLRX instead.

View recent insider trading info

Funds Holding PLRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PLRX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-11:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-17:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2022-03-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-10:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-09-07:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    30.5 Thousand total shares from 3 transactions

    Exercise Derivative Conversion (M)

    27.5 Thousand total shares from 2 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    LEFEBVRE ERIC CHIEF MEDICAL OFFICER

    • Officer
    138,436 2022-07-11 2

    COULIE BERNARD PRESIDENT AND CEO

    • Officer
    • Director
    1,200,125 2022-07-11 2

    PYOTT DAVID E I

    • Director
    15,000 2022-06-16 1

    CROWELL GAYLE A

    • Director
    15,000 2022-06-16 1

    HUH HOYOUNG

    • Director
    15,000 2022-06-16 1

    BRUHN SUZANNE LOUISE

    • Director
    15,000 2022-06-16 1

    CURNUTTE JOHN T

    • Director
    15,000 2022-06-16 1

    EXTER NEIL

    • Director
    15,000 2022-06-16 1

    SHAH SMITAL

    • Director
    15,000 2022-06-16 1

    HULL HANS CHIEF BUSINESS OFFICER

    • Officer
    112,500 2022-01-26 1

    CUMMINGS KEITH LAMONT CHIEF FINANCIAL OFFICER

    • Officer
    124,000 2022-01-26 2

    OUIMETTE MIKE GENERAL COUNSEL & CORP. SEC'Y

    • Officer
    87,000 2022-01-26 1

    HOMCY CHARLES J

    • Director
    13,286 2021-06-29 0

    HOWES BARBARA CHIEF HUMAN RESOURCE OFFICER

    • Officer
    0 2021-01-23 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    COULIE BERNARD - Director - Officer PRESIDENT AND CEO

    2022-07-13 19:05:39 -0400 2022-07-12 M 12,498 $2.08 a 71,771 direct -1.319 -4.9829 0.0 1 -6.1065 4

    COULIE BERNARD - Director - Officer PRESIDENT AND CEO

    2022-07-13 19:05:39 -0400 2022-07-12 S 12,498 $22.50 d 59,273 direct yes -1.319 -4.9829 0.0 1 -6.1065 4

    COULIE BERNARD - Director - Officer PRESIDENT AND CEO

    2022-07-13 19:05:39 -0400 2022-07-12 M 12,498 d 309,882 direct

    COULIE BERNARD - Director - Officer PRESIDENT AND CEO

    2022-07-13 19:05:39 -0400 2022-07-11 M 15,000 $2.08 a 74,273 direct -1.319 -4.9829 0.0 1 -6.1065 4

    COULIE BERNARD - Director - Officer PRESIDENT AND CEO

    2022-07-13 19:05:39 -0400 2022-07-11 S 15,000 $22.50 d 59,273 direct yes -1.319 -4.9829 0.0 1 -6.1065 4

    COULIE BERNARD - Director - Officer PRESIDENT AND CEO

    2022-07-13 19:05:39 -0400 2022-07-11 M 15,000 d 322,380 direct

    LEFEBVRE ERIC - Officer CHIEF MEDICAL OFFICER

    2022-07-13 19:06:38 -0400 2022-07-11 S 3,000 $20.00 d 138,436 direct yes -1.319 -4.9829 0.0 1 -6.1065 4

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 22:15:05 UTC 1.6827 0.6373 250000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 21:45:03 UTC 1.6827 0.6373 250000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 21:15:03 UTC 1.6827 0.6373 250000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 20:45:05 UTC 1.6799 0.6401 250000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 20:15:04 UTC 1.6799 0.6401 250000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 19:45:04 UTC 1.6799 0.6401 250000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 19:15:05 UTC 1.6799 0.6401 250000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 18:45:04 UTC 1.6799 0.6401 250000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 18:15:05 UTC 1.6799 0.6401 250000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 17:45:04 UTC 1.6799 0.6401 250000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 17:15:04 UTC 1.6799 0.6401 250000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 16:45:04 UTC 1.6799 0.6401 250000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 16:15:04 UTC 1.6799 0.6401 250000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 15:45:04 UTC 1.6799 0.6401 250000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 15:15:03 UTC 1.6799 0.6401 150000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 14:45:03 UTC 1.6799 0.6401 150000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 14:15:04 UTC 1.6799 0.6401 150000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 13:45:05 UTC 1.6782 0.6418 150000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 13:15:04 UTC 1.6782 0.6418 150000
    PLIANT THERAPEUTICS INC PLRX 2022-08-16 12:45:03 UTC 1.6782 0.6418 150000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments